Mortality and Cardiovascular Diseases in Adult-onset Type 1 Diabetes
Recruiting · NCT06563401 · Observational (researchers observe without assigning treatment) · Lead sponsor: Karolinska Institutet
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
Scarce evidence is available for prognosis in adult-onset type 1 diabetes (T1D). The aim of this study is to investigate the risk of all-cause mortality, cause-specific mortality, and incident CVD in adult-onset T1D, as compared to type 2 diabetes with comparable age at diagnosis and population controls. We will explore potential modifiable factors including lifestyle and clinical characteristics that contribute to T1D prognosis. In addition, we will estimate the life expectancy associated with different age at T1D diagnosis as compared to population controls. This study will be based on people with diabetes recorded in Swedish National Diabetes Registers, with linkages to other nationwide registers to retrieve data on lifestyle factors, biomarkers, treatment and outcome information.
Who can take part
Inclusion criteria
- people with adult-onset (≥18 years) T1D diagnosed in 2001-2020 from the National Diabetes Register
- all T2D cases diagnosed at age ≥18 years in 2001-2020 recorded in the National Diabetes Register
- Everyone with T1D was matched by age, sex, and county to 50 population controls from the Total Population Register.
Exclusion criteria
- To avoid diabetes secondary to pancreatic cancer, we excluded people diagnosed with cancer in the digestive system 1 year prior to diabetes diagnosis and with pancreatic cancer as the underlying cause of death.
Where it is running
1 location listed.
- Karolinska institute - Stockholm, Sweden